Glenmark-pharma_200
Glenmark launches antidiabetic drug in India January 3rd, 2024 11:27
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.

Stockarchitect

Stockarchitect

Stockarchitect

Stockarchitect

Stockarchitect

Stockarchitect
Buy Mahindra & Mahindra, target price Rs 2005: Motilal Oswal January 3rd, 2024 10:27
Mahindra & Mahindra Ltd. key Products/Revenue Segments include Automobile-Light, Medium & Heavy Commercial, Jeep, Passenger Car, Other Operating Revenue, Sale of services for the year ending 31-Mar-2023.

Stockarchitect
7 stocks close below VWAP on January 2 January 3rd, 2024 10:27
When the closing price falls below the VWAP, it signifies that the closing price is lower than the average price at which it was traded throughout the day, with the average being weighted by trading volume.

Stockarchitect
Sensex drops 200 points as global markets tumble; Nifty nears 21,600 January 3rd, 2024 10:27
From the Sensex stocks, Tata Steel, Wipro, Infosys, JSW Steel, HCL Tech and Tech Mahindra were the top laggards, falling 1-2%. On the flip side, Reliance, Sun Pharma, Bajaj Finance, Nestle, and M&M opened with gains.

Stockarchitect
Buy Avenue Supermarts, target price Rs 4400: Motilal Oswal January 3rd, 2024 10:27
Avenue Supermarts Ltd., incorporated in the year 2000, is a Large Cap company (having a market cap of Rs 261630.48 Crore) operating in Retail sector.

Load More